Clinical trials for a Covid-19 vaccine being carried out by Oxford University and AstraZeneca have restarted after a temporary halt was ordered when one of the volunteers fell ill.
The vaccine being developed at the prestigious university is one of the most promising of the numerous research projects being conducted around the world. EFE-EPA
vg/jt/ah
Source: efe.com , English edition
Комментариев нет:
Отправить комментарий